loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Latest Rapid Results

Open Free Trading Account Online with ICICIDIRECT
+91

Q4FY26 & FY26 Result Announced for Hindustan Oil Exploration Company Ltd.

Exploration & Production company Hindustan Oil Exploration Company announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • The company reported a negative Revenue from operations of Rs (19,057.09) lakh for Q4FY26, compared to a revenue of Rs 8,104.49 lakh in Q3FY26 and Rs 5,958.30 lakh in Q4FY25. This significant decline was primarily due to a revenue reversal of Rs 25,878.15 lakh related to a contract cancellation.
  • Total Income for Q4FY26 stood at Rs (19,918.34) lakh, showing a sharp decrease of 351.98% QoQ from Rs 7,910.64 lakh in Q3FY26 and a decrease of 298.25% YoY from Rs 10,047.20 lakh in Q4FY25.
  • Profit before tax for Q4FY26 was Rs 900.67 lakh, representing an increase of 31.33% QoQ from Rs 685.83 lakh in Q3FY26, but a decrease of 74.68% YoY compared to Rs 3,557.68 lakh in Q4FY25.
  • Net Profit (Profit for the period) for Q4FY26 was Rs 776.82 lakh, down 6.13% QoQ from Rs 827.56 lakh in Q3FY26 and down 84.82% YoY from Rs 5,115.93 lakh in Q4FY25.
  • For FY26, the company recorded a Revenue from operations of Rs 30,128.79 lakh, a decrease of 34.38% compared to Rs 45,912.09 lakh in FY25.
  • Annual Net Profit for FY26 stood at Rs 6,274.53 lakh, marking a decrease of 57.38% compared to Rs 14,720.77 lakh in the previous year FY25.
  • The Basic and Diluted Earnings Per Share (EPS) for FY26 was Rs 4.74, compared to Rs 11.13 in FY25.

Standalone Financial Highlights:

  • Revenue from operations for Q4FY26 was Rs (19,428.49) lakh, compared to Rs 7,732.32 lakh in Q3FY26 and Rs 14,260.97 lakh in Q4FY25.
  • Total Income for the quarter was Rs (20,331.19) lakh, a decrease from Rs 7,785.96 lakh in Q3FY26 and Rs 17,901.90 lakh in Q4FY25.
  • Net Profit for Q4FY26 stood at Rs 3,040.03 lakh, showing a growth of 154.18% QoQ from Rs 1,195.99 lakh in Q3FY26, but a decrease of 76.62% YoY from Rs 13,000.81 lakh in Q4FY25.
  • For FY26, standalone Revenue from operations reached Rs 28,802.59 lakh, a decrease of 16.24% from Rs 34,388.40 lakh in FY25.
  • Annual Standalone Net Profit for FY26 was Rs 10,961.06 lakh, compared to Rs 14,747.29 lakh in FY25, representing a decrease of 25.67%.

Business Highlights:

  • Segment Performance: The company operates as a single business segment, namely exploration, development, and production of crude oil and natural gas in India, both onshore and offshore.
  • Contract Cancellation (HPCL): During the quarter ended September 30, 2025, the company entered into a Crude Off take and Sale Agreement ("COSA") with HPCL. Revenue of Rs 25,878.15 lakh originally recognized was reversed in the current results following a mutual agreement to cancel the arrangement due to quality-related issues. New buyers have been identified, and the inventory has been recognized at an estimated net realizable value of Rs 27,262.85 lakh as of March 31, 2026.
  • Block B-80 Acquisition: During FY26, the company fully accounted for the 40% Participating Interest ("PI") of the other joint operator in Block B-80, following an application for assignment. Revenue and costs of Rs 5,499.89 lakh and Rs 5,271.44 lakh respectively were accounted for effective April 1, 2024.
  • Kharsang Block Transfer: The transfer of a 25% participating interest in the Kharsang Block from Geopetrol International Inc. was approved by the DGH on March 13, 2025, and has been accounted for using the pooling of interests method.
  • Labour Codes Impact: The company has recorded an incremental impact on Employee benefits expense amounting to Rs 128.49 lakh for the year ended March 31, 2026, due to the notification of the new Labour Codes.

Result PDF

Q4FY26 & FY26 Result Announced for Sumitomo Chemical India Ltd.

Agrochemicals company Sumitomo Chemical India announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • The company reported a Revenue from operations of Rs 6,837.43 million for Q4FY26, representing an increase of 20.38% QoQ compared to Rs 5,679.78 million in Q3FY26 and an increase of 0.64% YoY compared to Rs 6,794.21 million in Q4FY25.
  • Total Income for Q4FY26 stood at Rs 7,159.16 million, showing a growth of 18.35% QoQ from Rs 6,049.38 million in Q3FY26 and an increase of 0.69% YoY from Rs 7,110.41 million in Q4FY25.
  • Net Profit (Profit for the year) for Q4FY26 was Rs 1,113.16 million, marking a significant growth of 46.85% QoQ from Rs 758.00 million in Q3FY26 and an increase of 11.56% YoY compared to Rs 997.85 million in Q4FY25.
  • For FY26, the company achieved a Revenue from operations of Rs 32,383.15 million, an increase of 2.85% compared to Rs 31,485.24 million in FY25.
  • Annual Total Income for FY26 reached Rs 33,850.36 million, up 3.56% from Rs 32,686.24 million in the previous year.
  • Annual Net Profit for FY26 grew by 7.21% to Rs 5,429.75 million, compared to Rs 5,064.43 million in FY25.
  • The Basic and Diluted Earnings Per Share (EPS) for FY26 increased to Rs 10.88 from Rs 10.13 in FY25.

Standalone Financial Highlights:

  • Revenue from operations for Q4FY26 was Rs 6,714.91 million, a growth of 21.70% QoQ from Rs 5,517.58 million in Q3FY26 and 1.01% YoY from Rs 6,648.02 million in Q4FY25.
  • Total Income for the quarter was Rs 7,034.26 million, up 19.51% QoQ compared to Rs 5,885.73 million and 1.04% YoY compared to Rs 6,961.57 million.
  • Net Profit for Q4FY26 stood at Rs 1,106.10 million, an increase of 47.82% QoQ from Rs 748.26 million in Q3FY26 and 12.40% YoY from Rs 984.07 million in Q4FY25.
  • For the full year FY26, standalone Revenue from operations was Rs 31,857.62 million, an increase of 3.09% over FY25.
  • Annual Standalone Net Profit for FY26 was Rs 5,431.39 million, a growth of 8.21% compared to Rs 5,019.48 million in FY25.

Business Highlights:

  • Segment Performance: The company operates in only one reportable segment, which is the agro-chemicals segment.
  • Dividend: The Board of Directors has declared a dividend at the rate of 13% on equity shares of Rs 10 each (i.e., Rs 1.3 per equity share) for FY26, aggregating to Rs 648.89 million, subject to shareholder approval.
  • Exceptional Items: The company recorded a regulatory-driven, non-recurring exceptional item amounting to Rs 151.86 million (Standalone) and Rs 161.11 million (Consolidated) for the period ended 31st December, 2025, relating to the assessment of the financial impact of the new four Labour Codes notified by the Government of India.
  • Product Update (Glyphosate): A government notification mandating the use of Glyphosate only through Pest Control Operators remains under challenge in the Hon'ble Delhi High Court. The notification will not be implemented until the disposal of the petitions.

Result PDF

Q4FY26 & FY26 Result Announced for Innovassynth Technologies (India) Ltd.

Investment Companies company Innovassynth Technologies (India) announced Q4FY26 & FY26 results

Financial Highlights:

  • The company recorded a Total Income of Rs 5,094.67 lakh for Q4FY26, representing an increase of 130.76% from Rs 2,207.78 lakh in Q3FY26 (QoQ) and a growth of 4.01% from Rs 4,898.42 lakh in Q4FY25 (YoY).
  • Revenue from operations for Q4FY26 stood at Rs 5,082.67 lakh, marking a sequential increase of 131.32% compared to Rs 2,197.24 lakh in Q3FY26. On a year-on-year basis, revenue grew by 5.00% from Rs 4,840.66 lakh in Q4FY25.
  • For FY26, the company reported total Revenue from operations of Rs 10,235.21 lakh, an increase of 4.11% compared to Rs 9,831.35 lakh in FY25. Annual Total Income reached Rs 10,295.93 lakh, up by 2.87% from Rs 10,009.07 lakh in FY25.
  • Net Profit for Q4FY26 was Rs 1,195.13 lakh, a turnaround from a Net Loss of Rs 779.72 lakh in Q3FY26. Compared to Q4FY25, the Net Profit increased by 2.78% from Rs 1,162.86 lakh.
  • For FY26, the company incurred an annual Net Loss of Rs 2,878.80 lakh, as against a Net Profit of Rs 2,014.50 lakh in FY25.
  • Total Comprehensive Income for Q4FY26 was Rs 1,210.27 lakh, compared to a comprehensive loss of Rs 764.43 lakh in Q3FY26 and a comprehensive profit of Rs 1,180.85 lakh in Q4FY25.
  • The annual Total Comprehensive Loss for FY26 stood at Rs 2,848.37 lakh, as against a comprehensive income of Rs 2,004.64 lakh in FY25.
  • The Basic and Diluted Earnings Per Share (EPS) for Q4FY26 was Rs 1.58, compared to negative Rs 1.03 in Q3FY26 and Rs 1.54 in Q4FY25. For FY26, the EPS was negative Rs 3.82, compared to Rs 4.05 in FY25.

Business Highlights:

  • Merger and Corporate Name Change: The company completed the merger by absorption of its associate, Innovassynth Technologies (India) Limited ("ITIL"), with an appointed date of October 01, 2024. Following the merger becoming effective on December 19, 2025, the name of the company was officially changed from Innovassynth Investments Limited to Innovassynth Technologies (India) Limited.
  • Rights Issue Allotment: The company completed the allotment of 1,74,11,380 equity shares on a rights basis on May 19, 2026. The shares were issued at a price of Rs 40 per share (including a premium of Rs 30), aggregating to Rs 6,964.55 lakh, in the ratio of 3 Rights Equity Shares for every 13 fully paid-up Equity Shares.
  • Segment Performance: The company operates in a single reportable segment, namely the manufacturing of specialty chemicals and pharmaceutical intermediates. The company states that all other operating activities are incidental to its main business.
  • Labour Code Assessment: The company assessed an incremental impact of Rs 80.94 lakh on its financial results for FY26 under Employee Benefit Expenses due to the notification of the New Labour Codes, primarily arising from changes in the definition of wages and recognition of past service costs.
  • ESOP Allotment: On March 10, 2026, the company allotted 11,750 equity shares to eligible employees under the Dynacons - Employees Stock Option Plan 2020 (ESOP 2020) at an exercise price of Rs 10 per share.

Result PDF

Q4FY26 & FY26 Result Announced for Fermenta Biotech Ltd.

Pharmaceuticals company Fermenta Biotech announced Q4FY26 & FY26 results

Standalone Financial Highlights:

  • Quarterly Income: The company reported a Total Income of Rs 11,597.51 lakh in Q4FY26, representing a decrease of 1.44% compared to Rs 11,767.39 lakh in Q3FY26 (QoQ) and a decrease of 7.90% from Rs 12,592.09 lakh in Q4FY25 (YoY).
  • Quarterly Revenue: Revenue from operations for Q4FY26 stood at Rs 10,987.63 lakh, a decline of 3.82% QoQ from Rs 11,424.25 lakh and a decline of 9.97% YoY from Rs 12,203.79 lakh.
  • Quarterly Profit: Net Profit for Q4FY26 was Rs 2,157.28 lakh, showing a significant growth of 83.45% from Rs 1,175.92 lakh in Q3FY26. However, it decreased by 26.40% compared to Rs 2,931.12 lakh in Q4FY25.
  • Annual Income: For FY26, the company achieved a Total Income of Rs 47,415.16 lakh, up 7.22% from Rs 44,220.95 lakh in FY25.
  • Annual Revenue: Revenue from operations for FY26 reached Rs 45,025.27 lakh, a growth of 4.58% over Rs 43,053.17 lakh in FY25.
  • Annual Profit: Standalone Net Profit for FY26 was Rs 6,428.36 lakh, representing a marginal decrease of 4.93% compared to Rs 6,761.54 lakh in FY25.
  • Earnings Per Share (EPS): Standalone Basic EPS for FY26 stood at Rs 22.13 compared to Rs 23.18 in FY25.

Consolidated Financial Highlights:

  • Quarterly Income: Consolidated Total Income for Q4FY26 was Rs 12,664.73 lakh, a decrease of 9.85% from Rs 14,047.77 lakh in Q3FY26 (QoQ) and a decline of 11.89% from Rs 14,374.20 lakh in Q4FY25 (YoY).
  • Quarterly Revenue: Revenue from operations for Q4FY26 was Rs 12,158.34 lakh, down 11.50% QoQ from Rs 13,739.06 lakh and down 13.06% YoY from Rs 13,984.81 lakh.
  • Quarterly Profit: Consolidated Net Profit for Q4FY26 stood at Rs 1,860.03 lakh, a QoQ increase of 54.70% from Rs 1,202.31 lakh, but a YoY decline of 44.18% from Rs 3,332.34 lakh.
  • Annual Income: Consolidated Total Income for FY26 was Rs 54,781.46 lakh, reflecting an increase of 13.82% compared to Rs 48,129.58 lakh in FY25.
  • Annual Revenue: Annual Consolidated Revenue from operations reached Rs 52,542.94 lakh in FY26, up 11.92% from Rs 46,947.73 lakh in FY25.
  • Annual Profit: Consolidated Net Profit for FY26 was Rs 7,025.43 lakh, a decrease of 8.05% compared to Rs 7,640.28 lakh in FY25.
  • Earnings Per Share (EPS): Consolidated Basic EPS for FY26 stood at Rs 24.70 compared to Rs 26.35 in FY25.
  • Dividend: The Board has recommended a final equity dividend of Rs 3.75 per equity share of Rs 5 each (75%) for the financial year ended March 31, 2026.

Business Highlights:

  • Segment Performance:
    • Bulk drugs/chemicals: This segment contributed Rs 51,472.17 lakh to the total revenue in FY26, showing a growth of 28.52% over Rs 40,048.76 lakh in FY25.
    • Property: Revenue from this segment was Rs 951.27 lakh in FY26, a sharp decline compared to Rs 5,440.18 lakh in FY25.
  • Exceptional Items: The company recorded an exceptional item (expense) of Rs 798 lakh in the consolidated results for FY26 (standalone Rs 444 lakh). This pertains to an impairment loss for certain non-operational plants located in India and a subsidiary plant in Malaysia.
  • Asset Monetization: During FY26, the company sold parts of its freehold land at Village Takave and commercial property in Ceejay House, Worli, Mumbai. Standalone revenue under "Other Income" from these property sales amounted to Rs 856.23 lakh for FY26.

Prashant Nagre, Managing Director, said: “The turnaround of FY25 was further confirmed in FY26. While growth of revenue, excluding that from real estate unlocking, was 57% in FY25 over FY24, in FY26 revenue growth was 26% over FY25. On the underlying operating business, as explained above, with that one-time inflow stripped from both periods, PAT quality has in fact strengthened over the year.

Our FY26 EBITDA (excluding real estate) demonstrates robust operational leverage— as it surpassed our FY25 EBITDA by 44%.

Our sustained efforts over the years in expanding the enzymes portfolio and their application & customer base have started yielding initial results. We are confident of continuing to expand & grow this portfolio.

While human nutrition volumes grew by 43% in FY25 over FY24, we have further seen the volumes grow by 21% in FY26 over FY25.

Our sustained volume momentum, combined with improving margins, positions Fermenta well for continued value creation.

We remain focused on scaling our core human nutrition business while exploring strategic opportunities. FY26 delivered the foundational layer for our two flagship product introductions — the granted Indian process patent for plant-based Vitamin D3 secured in September 2025, the EDQM Certificate of Suitability for the Vitamin D3 100 SD premix, and the Letter of Approval from the Global Alliance for Improved Nutrition. Commercial launches of VITADEE Green and Vitamin D3 100 SD are now sequenced for FY27, in line with the patent-certification-capacity-launch sequence appropriate to pharmaceutical-grade chemistry. Our ongoing capex at Dahej will establish commercial-scale production of plant-based Vitamin D3 (for which we hold Indian patent protection) alongside new Vitamin D3 derivatives. This strengthens our position as one of the world's leading fully integrated Vitamin D3 manufacturers.

Result PDF

Q4FY26 & FY26 Result Announced for Prime Securities Ltd.

Financial Services company Prime Securities announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • The company reported a Total Income of Rs 3,078 lakh for Q4FY26, showing an increase of 1.95% compared to Rs 3,019 lakh in Q3FY26 (QoQ) and a significant growth of 142.17% compared to Rs 1,271 lakh in Q4FY25 (YoY).
  • For FY26, Total Income stood at Rs 13,799 lakh, an increase of 54.35% from Rs 8,940 lakh in FY25.
  • Revenue from Operations (Fee and commission income) for Q4FY26 was Rs 2,934 lakh, as against Rs 2,938 lakh in Q3FY26 and Rs 1,079 lakh in Q4FY25.
  • For FY26, Revenue from Operations reached Rs 12,768 lakh, compared to Rs 7,980 lakh in FY25, marking a growth of 60.00%.
  • The company incurred a Net Loss after tax and share of profit/(loss) of associate of Rs 1,322 lakh in Q4FY26, compared to a profit of Rs 210 lakh in Q3FY26 and a profit of Rs 77 lakh in Q4FY25.
  • For FY26, the company reported a Net Profit after tax and share of profit/(loss) of associate of Rs 1,316 lakh, compared to Rs 3,827 lakh in FY25.
  • Total Comprehensive Income for Q4FY26 stood at Rs 883 lakh, compared to Rs 239 lakh in Q3FY26 and Rs 908 lakh in Q4FY25. For FY26, it was Rs 3,945 lakh as against Rs 5,065 lakh in FY25.
  • Basic Earnings Per Share (EPS) for FY26 was Rs 3.91, compared to Rs 11.49 in FY25.

Standalone Financial Highlights:

  • Total Income for Q4FY26 was Rs 800 lakh, representing a decrease of 39.12% from Rs 1,314 lakh in Q3FY26 (QoQ) and an increase of 63.60% from Rs 489 lakh in Q4FY25 (YoY).
  • For FY26, Standalone Total Income reached Rs 5,456 lakh, compared to Rs 5,647 lakh in FY25.
  • Revenue from Operations for Q4FY26 stood at Rs 725 lakh, compared to Rs 1,296 lakh in Q3FY26 and Rs 375 lakh in Q4FY25.
  • Net Loss after tax for Q4FY26 was Rs 372 lakh, as against a profit of Rs 415 lakh in Q3FY26 and a profit of Rs 112 lakh in Q4FY25.
  • For FY26, Standalone Net Profit after tax was Rs 1,768 lakh, compared to Rs 3,225 lakh in the previous year.
  • Total Comprehensive Income for FY26 was Rs 3,826 lakh, compared to Rs 4,465 lakh in FY25.
  • Standalone Basic EPS for FY26 stood at Rs 5.25, as against Rs 9.62 in FY25.

Business Highlights:

  • Segment Performance: The Group has only one segment of business i.e. Financial Advisory and Intermediation services. There are no separate reportable segments in terms of Ind-AS 108.
  • Watershed Year: The company identified FY26 as a watershed year for the company and its subsidiaries.
  • Revenue Growth: Consolidated Revenues reached an all-time high of Rs 138 crore, reflecting a 54% full year growth.
  • Investment Banking and Advisory: This core business segment generated revenues of Rs 116.50 crore and a Profit Before Tax (PBT) of Rs 42.14 crore in FY26.
  • Wealth Management Subsidiary: Prime Trigen Wealth, the wealth management subsidiary, posted revenues of Rs 21.48 crore in its first full year of operations.
  • AUM / AUA: The Assets Under Management (AUM) / Assets Under Advice (AUA) as on March 31, 2026, is approximately Rs 3,500 crore.
  • Liquidity Position: Cash plus Investments as on March 31, 2026, stood at approximately Rs 250 crore.
  • Client Onboarding: Trigen Wealth has onboarded 850 clients and 600 families in the first year of its operations, operating from 9 locations with over 100 employees.
  • MAT Recognition: The Holding Company has recognised Minimum Alternate Tax (MAT) for the first time consisting of eligible but unutilised MAT paid in the past years. Unabsorbed MAT aggregating to Rs 841 lakh was recognised during the year.
  • Exceptional Item: A subsidiary, Prime Research and Advisory Limited (PRAL), recognized an Expected Credit Loss (ECL) allowance of Rs 1,178 lakh against contract assets arising out of a claim of Rs 2,795 lakh currently subject to adjudication before the Hon'ble National Company Law Tribunal (NCLT).

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app